Medtronic snags FDA approval for next-generation pacemaker
Medtronic snags FDA approval for next-generation pacemaker via @WhiteCityNews
Medtronic ($MDT) snagged FDA approval for its next-generation cardiac resynchronization therapy (CRT) pacemaker in patients with heart failure, expanding its cardiovascular portfolio and advancing its proprietary technology for heart rhythm therapy.
(more…)
View On WordPress














